Morningstar
•
Apr 29, 2026
Haleon plc: Haleon Earnings: Weak Consumer Health Pressures Volume, but Bright Spots Still Exist
Summary
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs an
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Daily – Vickers Top Buyers & Sellers for 05/01/2026
May 01, 2026
•
ANIK, AGX, PRCH, FIX, PBF, CAR, PDX, GEHC, GRNQ
Analyst Report: GSK plc
Apr 30, 2026
•
GSK
Analyst Report: GE HealthCare Technologies Inc.
Apr 29, 2026
•
GEHC
Analyst Report: Alcon Inc.
Apr 29, 2026
•
ALC
Analyst Report: GE HealthCare Technologies Inc.
Apr 29, 2026
•
GEHC

